Latest News | Pivotal CRO

Staidson and Pivotal to collaborate in European Clinical trial of progressive severe Covid-19 patients

June 8, 2020

The phase II, multicenter, open-label, randomized and controlled clinical trial will research whether BDB-001, a recombinant injectable humanized anti-human C5a monoclonal antibody, has a promising role in the treatment...

Pivotal´s collaboration with children´s vaccination in the poorest countries

May 25, 2020

Pivotal has adhered to the Alliance for Children´s Vaccination

Pivotal collaborates along with Gavi, an international organization and global Vaccine Alliance, in the fight...

ICT Media met with Barbara D´Haene and Nathalie Niclaus at Akcelis to talk on the current make-up of patient enrolment

May 11, 2020

If you would like to read the full article please go to the following link: ICT media (This article is extracted from International Clinical Trials May 2020, page...

Pivotal is providing its specialized clinical research services for the conduct of a clinical trial in patients with COVID-19

April 28, 2020

The clinical trial, which plans to include a total of up to 300 patients, has recently begun to include the first patients in Madrid and will incorporate up to...

Pivotal acquires Akcelis, an industry leader in patient engagement, recruitment and retention

March 3, 2020

New patients´ enrollment model to accelerate drug development

Pivotal announced today the acquisition of Akcelis BVBA, a leading full-service provider of patients´ enrollment and retention solutions for clinical trials...

Pivotal has participated in the 38th annual JP Morgan healthcare conference

February 12, 2020

The annual conference was held in San Francisco (California)

Pivotal, represented by members of our Senior Management, has participated in the 38th Annual JP Morgan HealthCare Conference held in...

Pivotal to provide services to Lucid Diagnostics clinical studies for its GI in-vitro diagnostics Esoguard™ & Esocheck™

February 11, 2020

Two multinational multicenter clinical studies launched early 2020 to support regulatory clearance of EsoGuard/EsoCheck as an FDA-registered In-Vitro Diagnostic (IVD)
Will research Barrett’s Esophagus (BE), with and without dysplasia,...

Pivotal at the GDPR summit celebrated in Brussels

November 25, 2019

Pivotal’s QA & Compliance Director Francisco Calvo recently participated in Brussels in an interactive conference on GDPR

Pivotal’s QA & Compliance Director Francisco Calvo recently participated in Brussels in...

Pivotal at the European Society for Medical Oncology (ESMO)

October 8, 2019

Pivotal has recently participated with a booth number 451 at the ESMO congress in Barcelona, which ended on Tuesday, October 1st 2019

Pivotal’s management team met with different important...

News